Sökning: onr:"swepub:oai:lup.lub.lu.se:cc8583a0-437e-4095-8a9c-24bf97f3861f" >
Cyclosporine-A enha...
-
Borlongan, C V
(författare)
Cyclosporine-A enhances choline acetyltransferase immunoreactivity in the septal region of adult rats
- Artikel/kapitelEngelska2000
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:cc8583a0-437e-4095-8a9c-24bf97f3861f
-
https://lup.lub.lu.se/record/1116821URI
-
https://doi.org/10.1016/S0304-3940(99)00962-3DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Cyclosporine-A (CsA) is the primary anti-rejection drug used for organ and neural transplantation therapy. In addition to its immunosuppressive action, CsA has been recently shown to exert neuroprotective and neurotrophic effects in the central nervous system when able to cross the blood-brain barrier. Postulated mechanisms for these CsA-induced beneficial effects include the drug's powerful inhibition of the calcium-dependent phosphatase calcineurin (CN) and blockade of the assembly of the mitochondrial permeability transition pore. We report here, for the first time, that adult Wistar rats treated with CsA (10 mg/kg per day, i.p. for 9 days) displayed significantly reduced septal CN expression in combination with enhanced levels of septal choline acetyltransferase (ChAT) immunoreactivity as compared to controls. The observed enhancement of septal ChAT immunoreactivity suggests potential therapeutic utility of CsA for brain disorders characterized by alterations of the cholinergic system.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Stahl, C E
(författare)
-
Keep, M F
(författare)
-
Elmer, EskilLund University,Lunds universitet,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)expb-eel
(författare)
-
Watanabe, S
(författare)
-
Sektion IVInstitutionen för kliniska vetenskaper, Lund
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Neuroscience Letters279:2, s. 73-760304-3940
Internetlänk
Hitta via bibliotek
Till lärosätets databas